Skip to main content
. 2016 Mar 7;11(3):e0150791. doi: 10.1371/journal.pone.0150791

Table 2. Serum lipid analysis of low-density lipoprotein receptor-knockout (LDLr KO) mice fed a HFD with treatment of pravastatin or pravastatin plus sarpogrelate.

Milligrams/deciliter NFD HFD HFD + PRA 40 mg/kg HFD + PRA 40 mg/kg + SAR 50 mg/kg
Total cholesterol 351.1 ± 17.67 2132 ± 111.1 1353 ± 104.3 *** 1446 ± 84.13 ***
Triglycerides 113.3 ± 11.94 1048 ± 195.1 232.0 ± 33.29 *** 377.1 ± 18.00 **
HDL cholesterol 100.7 ± 3.496 87.25 ± 5.593 89.50 ± 2.693 84.50 ± 3.813
LDL cholesterol 111.1 ± 7.818 787.5 ± 40.64 512.5 ± 32.14 ** 542.3 ± 34.37 **

Data represented as mean ± standard error and significance was analyzed by Student’s t-test (**,*** denote significant difference to HFD group, **P < 0.01, ***P < 0.001, n = 7–8/group).

Abbreviations: NFD, normal fat diet; HFD, high fat diet; SAR, sarpogrelate; PRA, pravastatin